Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Obes Surg ; 24(1): 2-8, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23963882

ABSTRACT

BACKGROUND: This study aims to evaluate results on revision surgery for weight regain after gastric bypass, based on surgical technique and follow-up. METHODS: This study is a retrospective analysis of 29 patients who presented weight regain on follow-up after more than 5 years, divided into four groups according to revision surgery type: group 1 (n = 9) includes patients who underwent an increase in the length of the alimentary limb to 200 cm; group 2 (n = 13) are patients who underwent an increase in the length of the alimentary limb and placing of a silicon ring; group 3 (n = 2) are patients who underwent an increase in the length of the alimentary limb and gastric plication, and group 4 (n = 5) are patients who underwent gastric plication and placing of a silicon ring. RESULTS: The average preoperative weight before revision surgery was 117.8 kg, and the average postoperative follow-up for revision surgery was 13.7 months. Weight loss after revision surgery was observed in all groups but was greater in patients with longer revisional postoperative follow-up. Patients who underwent placing of a silicon ring presented greater weight loss than those who had had such a band since the original gastric bypass operation. CONCLUSIONS: Data suggest that revision surgery may be a useful tool in achieving weight loss in patients presenting weight regain following gastric bypass, obesity, bariatric surgery, gastric bypass, weight regain, and revision surgery.


Subject(s)
Gastric Bypass/adverse effects , Obesity, Morbid/surgery , Reoperation/methods , Weight Gain , Adult , Female , Humans , Male , Retrospective Studies
2.
Rev Col Bras Cir ; 38(1): 35-40, 2011.
Article in English, Portuguese | MEDLINE | ID: mdl-21537741

ABSTRACT

OBJECTIVE: To evaluate the morbidity and mortality in surgical treatment of schistosomal portal hypertension in patients with inversion of the Portal/Splenic Vein diameter ratio. METHODS: We conducted a retrospective cross-sectional study of patients undergoing surgical treatment of portal hypertension in the period between September 1993 and January 2004. The study population was divided into two groups: a) Inversion--splenic vein diameter greater than or equal to portal vein's--and b) control group (portal vein diameter greater than the splenic vein's). Statistical comparisons used the Student t test for averages difference, chi-square test for proportions difference and Fisher's exact test for small samples. RESULTS: 169 patients were analyzed, with follow-up averaging 23.6 months. Twenty-one patients (12.4%) had splenic vein caliber greater of equal than the portal vein's (Inversion--study group). The mean preoperative diameter of the portal and splenic veins were respectively 1.49 and 1.14 cm in the control group, and 0.98 versus 1.07 cm in the inversion group. The portal vein diameter was significantly higher in the control group when compared to the inversion group (p <0.05). Varices in the gastric fundus were found in 33.3% of the inversion group and in 38.5% of patients in the control group. Postoperative rebleeding occurred in 23.1% of patients in the inversion group and in 13.4% of the control group ones (p > 0.05). In the postoperative evaluation with Doppler ultrasonography of portal vessels, no cases of portal vein thrombosis were observed in the inversion group, whilst in the control group portal thrombosis was identified in 16.9% of the patients (p <0.05). Death occurred in one (4.8%) individual from the inversion group; mortality was 4.1% in the control group (p>0.05). The mean serum level of platelets was significantly lower (65,950/mm²) in the inversion group than in the controls (106,647/mm²) (p<0.05). CONCLUSION: The results suggest that the reversal of portal/splenic vein caliber ratio does not represent a contraindication to surgical treatment of schistosomal portal hypertension.


Subject(s)
Hypertension, Portal/parasitology , Hypertension, Portal/surgery , Schistosomiasis/surgery , Adult , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Organ Size , Portal Vein/anatomy & histology , Portal Vein/diagnostic imaging , Retrospective Studies , Splenic Vein/anatomy & histology , Splenic Vein/diagnostic imaging , Ultrasonography , Vascular Surgical Procedures/methods , Young Adult
3.
Arq Gastroenterol ; 43(2): 85-8, 2006.
Article in Portuguese | MEDLINE | ID: mdl-17119660

ABSTRACT

BACKGROUND: Correlation between infectious agents and linfoproliferative diseases are more stablished, over all virus and bacteria, through the activation of linfocytes. AIM: To describe six new cases, of a series of 254 patients (2,36%) with mansonic schistosomiasis, in the hepatosplenic form. METHODS: Six patients will be described, amongst the 254 carriers of mansonic schistosomiasis, in the hepatosplenic form, followed in the last 13 years. RESULTS: All the six cases had occurred in women. The histopathologic examinations had evidenced two cases of marginal splenic zone lymphomas, one of great cells with immunoblasts lymphomas, one diffuse lymphomas, a great cells malignant lymphomas, a great not clivads cells, and another case of Hodgkin. Half of the six evolved for the death 4-15 months after the diagnosis. The others three persist in accompaniment in the Oncology Division of the Clinics Hospital. CONCLUSION: The incidence of lymphomas in the 254 mansonic schistosomiasis patients followed in our clinic was of 2,36%. At last, this article intends to call the attention, for the occurrence of lymphomas, in the spleen of patients with mansonic schistosomiasis, in the hepatosplenic form.


Subject(s)
Liver Diseases, Parasitic/complications , Lymphoma/complications , Schistosomiasis mansoni/complications , Splenic Diseases/complications , Adult , Aged , Female , Humans , Lymphoma/diagnosis , Middle Aged , Splenic Neoplasms/complications , Splenic Neoplasms/diagnosis
4.
Arq Gastroenterol ; 40(1): 4-10, 2003.
Article in English | MEDLINE | ID: mdl-14534657

ABSTRACT

AIM: To evaluate the degree of influence that periportal fibrosis has on clinical development and the long term results of surgical treatment on patients with hepatic-splenic schistosomiasis with previous gastrointestinal hemorrhages. METHODS: During the period of 1992-1998, 111 patients underwent surgical treatment for the treatment of hepatic-splenic schistosomiasis with previous gastrointestinal hemorrhages. The degree of fibrosis was classified as: degree I - the portal spaces show a rich increase of young connective cells, a slight collagen production and a varying presence of inflammatory infiltrate. The periportal blade unchangeable (29/111); degree II - there is an expansion of the connective tissue with the emission of radial collagen septa, producing a star shaped aspect (38/111); degree III - the connective septa form bridges with other portal spaces or with the vein, with evident angiomatoid neo-formation (44/111). CONCLUSION: The patients with periportal fibrosis degree I present recurrent hemorrhages statistically less than patients with periportal fibrosis degrees II and III, and that the intensity of the periportal fibrosis is not the only pathophysiological factor of the esophageal varices, gastric varices, prevalence of post-operative portal vein thrombosis and hematological and biochemical alterations of the patients with pure mansoni schistosomiasis.


Subject(s)
Gastrointestinal Hemorrhage/surgery , Hypertension, Portal/surgery , Portal Vein/pathology , Schistosomiasis mansoni/surgery , Adult , Esophageal and Gastric Varices/surgery , Female , Fibrosis , Follow-Up Studies , Humans , Hypertension, Portal/parasitology , Liver Diseases, Parasitic/surgery , Male , Middle Aged , Recurrence , Schistosomiasis mansoni/complications , Splenic Diseases/parasitology , Splenic Diseases/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...